•
Jul 03, 2020

Danaher Q2 2020 Earnings Report

Danaher's Q2 2020 performance was marked by revenue growth, strong cash flow, and adjusted EPS growth.

Key Takeaways

Danaher Corporation reported a strong second quarter with a 19.0% increase in revenues to $5.3 billion and a 38.0% increase in net earnings per share to $1.24. Non-GAAP adjusted diluted net earnings per share were $1.44, a 32.0% increase. The company's performance was driven by its team's commitment to the Danaher Business System and its portfolio of businesses.

Revenues increased by 19.0% year-over-year to $5.3 billion.

Net earnings were $927.3 million, or $1.24 per diluted common share, a 38.0% year-over-year increase.

Non-GAAP adjusted diluted net earnings per common share were $1.44, a 32.0% increase year-over-year.

Operating cash flow was $1.4 billion, a 37.0% increase year-over-year, and non-GAAP free cash flow was $1.3 billion, a 41.0% increase year-over-year.

Total Revenue
$5.3B
Previous year: $5.16B
+2.7%
EPS
$1.44
Previous year: $1.19
+21.0%
Core Sales Growth
3.5%
Gross Profit
$2.85B
Previous year: $2.88B
-0.9%
Cash and Equivalents
$5.54B
Previous year: $5.43B
+1.9%
Free Cash Flow
$1.3B
Previous year: $975M
+33.3%
Total Assets
$71.3B
Previous year: $53.3B
+33.7%

Danaher

Danaher

Forward Guidance

The Company anticipates that non-GAAP core revenue growth including Cytiva will be in the mid- to high-single digit range for the third quarter 2020.